Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion type Assertion NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_head.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion evidence source_evidence_literature NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion SIO_000772 25644941 NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion wasDerivedFrom befree-2016 NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion wasGeneratedBy ECO_0000203 NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.